Home Patients & Families Professionals Screening Research About Us Contact
SCA Home | Research | Cancer Research | Dr. Vizeacoumar
Research
Font Size:  a a a
Dr. Franco Vizeacoumar

Franco Vizeacoumar
Research Scientist
Saskatchewan Cancer Agency
Adjunct Professor, Division of Oncology
Associate Member, Department of Pathology
University of Saskatchewan

Location:
Cancer Cluster
Room 4D01.5 Health Sciences Building
107 Wiggins Road
University of Saskatchewan
Saskatoon, SK S7N 4E5
Phone: 306-966-7010
email: franco.vizeacoumar@saskcancer.ca

Historically cancer has been studied and treated based on body parts. However, the advent of cost-efficient genome sequencing has revealed that only a handful of genes are frequently altered in a high percentage of tumors. A key message from these studies is that therapeutic approaches should aim at the genetic basis rather than the tissue of origin. This knowledge and the availability of highly selective inhibitors of gene products, promises a genotype-directed cancer therapy. Our lab is interested in developing such a genotype-directed cancer therapy for solid tumors by applying a basic biological concept called synthetic lethality. In effect, any genetic alteration that can cause selective-lethality with an oncogenic or a tumor suppressor mutation can be potentially translated into a therapeutic target. This will ultimately enable personalized medicine in which patients having disease of similar biological origin will likely benefit from a specific drug treatment. Our long term goal is to build a synthetic lethal network that will enable us to understand the genetic dependencies of cancer cells and define key therapeutic targets.

More information is available at www.usask.ca/~franco.vizeacoumar

 

ff
SCA Home | Research | Cancer Research | Dr. Vizeacoumar